Trials / Completed
CompletedNCT01169571
Study to Evaluate Hemodynamic Effect of Different Loading Doses of Precedex in Post-surgical Intensive Care Unit (ICU) Patients
Phase 4, Open-Label Study Evaluating the Hemodynamic Effect of Differing Loading Regimens of Precedex in a Post-Surgical Intensive Care Patient Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 373 (actual)
- Sponsor
- Hospira, now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to characterize the hemodynamic effects of Precedex (dexmedetomidine (DEX)) during 3 loading-dose paradigms in mechanically ventilated post-surgical subjects in an intensive care setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-07-26
- Last updated
- 2015-07-24
Locations
17 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01169571. Inclusion in this directory is not an endorsement.